Logo image of CLNY

Colony Capital Inc (CLNY) Stock Fundamental Analysis

NYSE:CLNY - New York Stock Exchange, Inc. -

8.5  +0.52 (+6.52%)

After market: 8.18 -0.32 (-3.76%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CLNY. CLNY was compared to 130 industry peers in the Diversified REITs industry. CLNY may be in some trouble as it scores bad on both profitability and health. CLNY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CLNY has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -15.52%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -140.48%
PM (TTM) -193.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

There is no outstanding debt for CLNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CLNY has a Debt/Equity ratio of 1.08. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.39% over the past year.
CLNY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -41.59%.
Measured over the past years, CLNY shows a quite strong growth in Revenue. The Revenue has been growing by 9.25% on average per year.
EPS 1Y (TTM)37.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)-41.59%
Revenue growth 3Y-21.43%
Revenue growth 5Y9.25%
Sales Q2Q%-37.79%

3.2 Future

The Earnings Per Share is expected to grow by 14.61% on average over the next years. This is quite good.
Based on estimates for the next years, CLNY will show a small growth in Revenue. The Revenue will grow by 2.23% on average per year.
EPS Next Y21.74%
EPS Next 2Y37.1%
EPS Next 3Y23.9%
EPS Next 5Y14.61%
Revenue Next Year-20.16%
Revenue Next 2Y-9.7%
Revenue Next 3Y-1.73%
Revenue Next 5Y2.23%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLNY Yearly Revenue VS EstimatesCLNY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CLNY Yearly EPS VS EstimatesCLNY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CLNY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CLNY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLNY Price Earnings VS Forward Price EarningsCLNY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -14.69
CLNY Per share dataCLNY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

CLNY's earnings are expected to grow with 23.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.1%
EPS Next 3Y23.9%

More info and screens

1

5. Dividend

5.1 Amount

CLNY has a Yearly Dividend Yield of 1.29%. Purely for dividend investing, there may be better candidates out there.
With a Dividend Yield of 1.29, CLNY pays less dividend than the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 1.29%

5.2 History

The dividend of CLNY decreases each year by -22.76%.
CLNY has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-22.76%
Div Incr YearsN/A
Div Non Decr YearsN/A
CLNY Yearly Dividends per shareCLNY Yearly Dividends per shareYearly Dividends per share 2015 2016 2018 2019 2020 0.5 1 1.5

5.3 Sustainability

The earnings of CLNY are negative and hence is the payout ratio. CLNY will probably not be able to sustain this dividend level.
DP-4.92%
EPS Next 2Y37.1%
EPS Next 3Y23.9%

More info and screens

Colony Capital Inc

NYSE:CLNY (6/21/2021, 8:04:00 PM)

After market: 8.18 -0.32 (-3.76%)

8.5

+0.52 (+6.52%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners1.22%
Ins Owner Change0%
Market Cap4.14B
Analysts100
Price Target8.61 (1.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.29%
Yearly Dividend0.11
Dividend Growth(5Y)-22.76%
DP-4.92%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.1
P/FCF N/A
P/OCF N/A
P/B 0.65
P/tB N/A
EV/EBITDA -14.69
EPS(TTM)-1.39
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.74
BVpS13.04
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.52%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -140.48%
PM (TTM) -193.24%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y21.74%
EPS Next 2Y37.1%
EPS Next 3Y23.9%
EPS Next 5Y14.61%
Revenue 1Y (TTM)-41.59%
Revenue growth 3Y-21.43%
Revenue growth 5Y9.25%
Sales Q2Q%-37.79%
Revenue Next Year-20.16%
Revenue Next 2Y-9.7%
Revenue Next 3Y-1.73%
Revenue Next 5Y2.23%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A